Skip to main content
OpenTrials
Completed

NCT Number: NCT05765305

Combined Chromium With Letrozole Versus Letrozole Only in Induction of Ovulation in Patients With Polycystic Ovary Syndrome

Combined letrozole with chromium versus letrozole only in induction of ovulation in polycystic ovary syndrome

Completed

Looking for future studies?

Notify Me

Key information

About this study

Randomized controlled trial

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • female patients aged from 18 to 35 years Anovulatory cycles Pcos

Exclusion criteria

  • female patients aged more than 35years Male factor of infertility Other factors of infertility than pcos

Treatment and study plan

Letrozole with chromium

Drug

Letrozole versus letrozole with chromium

Primary outcomes

  1. Efficacy of letrozole

    Time frame: 12 months

    efficacy of letrozole with chromium in improving induction of ovulation

Secondary outcomes

  1. Miscarriage rate

    Time frame: 12 months

    Incidence of OHSS

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Letrozole and Chromium

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Mar 13, 2023
Registry last updated
Mar 15, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.